Biotron (ASX:BIT) has announced the acquisition of Sedarex, the owner of global patents for SedRx, a next-generation general anaesthetic with the potential to reshape the $6.5 billion global anaesthesia market. The deal is backed by a $2.5 million capital raising through a placement and rights offer, led by Peak Asset Management. …
Biotron to acquire Sedarex and raise $2.5 million to accelerate anaesthetic program
October 15, 2025 Australian Biotech
Latest Video
New Stories
-
The 'Dispatched' Podcast - Week in review
August 7, 2026 - - Podcast -
argenx partners with Monash University and Myostellar to develop muscular therapies
August 7, 2026 - - Latest News -
A new generation is rewriting their lives living with Cystic Fibrosis
August 7, 2026 - - Latest News -
US approves Moderna's mRNA flu vaccine in major technology milestone
August 7, 2026 - - Latest News -
If Australian companies shun their domestic market, who can blame multinationals?
August 6, 2026 - - Latest News -
Neuren reports record DAYBUE sales as royalties rise and global expansion nears
August 6, 2026 - - Australian Biotech -
Moderna begins Phase 1 trial of vaccine candidate against Bundibugyo Ebola Virus
August 6, 2026 - - Latest News